6634 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Sinew Pharma, Inc. engages in the research and development of drugs related to liver disease treatment and pain treatment. It develops acetaminophen, drugs for non-alcoholic steatohepatitis, and acetaminophen poisoning antidotes. The company was founded by Kai Min Chu on June 18, 2014 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6634 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company